Literature DB >> 16427444

Stereotactic computed tomography-guided brain biopsy: diagnostic yield based on a series of 170 patients.

Marcelo Paglioli Ferreira1, Nelson Pires Ferreira, Arthur de Azambuja Pereira Filho, Gustavo de Azambuja Pereira Filho, André Cerutti Franciscatto.   

Abstract

BACKGROUND: Stereotactic CT-guided biopsy is a valuable and safe procedure for diagnosing intracranial lesions. The objectives of this article are to analyze the diagnostic yield in a series of stereotactic CT-guided brain biopsies and to evaluate whether predictive factors may influence diagnostic yield.
METHODS: The medical records of a series of patients who underwent stereotactic CT-guided brain biopsy from 1993 to 2005 in a neurosurgical center were reviewed. Clinical data were stored and analyzed with Microsoft Access (Microsoft Corp, Seattle, WA) and SPSS V11.0 software (SPSS, Inc, Chicago, IL). The following variables were analyzed: age, sex, anatomopathologic diagnosis, lesion topography and volume, postsurgical complications, and predictive factors that may affect diagnostic yield.
RESULTS: One hundred seventy patients (102 males, 68 females; average age, 48.5 years) were analyzed. Stereotactic CT-guided biopsies allowed diagnosis in 157 cases (92%). The most frequent anatomopathologic diagnoses were high-grade glioma (n = 45), low-grade glioma (n = 31), nonspecific inflammatory lesions (n = 19), metastasis (n = 10), and lymphoma (n = 10). The most frequent topographies were frontal (n = 42), basal ganglia (n = 40), and parietal (n = 27) and front-parietal lobes (n = 9). Complications occurred in 5 patients (2.9%). Mortality rate was 1.2% (2 patients). Age had a positive impact, whereas female sex negatively affected diagnostic yield. All other predictive factors analyzed were not significant.
CONCLUSION: Stereotactic CT-guided brain biopsies performed presented acceptable anatomopathologic diagnostic rate. Age had a positive impact, whereas female sex negatively affected diagnostic yield in this series.

Entities:  

Mesh:

Year:  2006        PMID: 16427444     DOI: 10.1016/j.surneu.2005.11.036

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

Review 1.  Is the brain biopsy obligatory or not for the diagnosis of Schilder's disease? Review of the literature.

Authors:  Yuksel Yilmaz; Canan Kocaman; Hakan Karabagli; Memet Ozek
Journal:  Childs Nerv Syst       Date:  2007-08-25       Impact factor: 1.475

2.  Achieving Higher Diagnostic Results in Stereotactic Brain Biopsy by Simple and Novel Technique.

Authors:  Salih Gulsen
Journal:  Open Access Maced J Med Sci       Date:  2015-01-22

3.  Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas.

Authors:  Sophie Katzendobler; Anna Do; Jonathan Weller; Mario M Dorostkar; Nathalie L Albert; Robert Forbrig; Maximilian Niyazi; Rupert Egensperger; Niklas Thon; Joerg Christian Tonn; Stefanie Quach
Journal:  Front Neurol       Date:  2022-03-30       Impact factor: 4.003

Review 4.  Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.

Authors:  Eliza M Lauer; Jurik Mutter; Florian Scherer
Journal:  Leukemia       Date:  2022-06-14       Impact factor: 12.883

5.  Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures.

Authors:  Jan-Oliver Neumann; Benito Campos; Bilal Younes; Martin Jakobs; Christine Jungk; Christopher Beynon; Andreas von Deimling; Andreas Unterberg; Karl Kiening
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.